1.
PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. J of Skin. 2023;7(6):s237. doi:10.25251/skin.7.supp.237